NCT05050877

Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention II

Completed Last updated 21 September 2021

What this trial tests

trial in Cardio-Renal Syndrome in 184,855 participants. Completed in 31 December 2020.

Timeline

1 June 2000

Primary endpoint
31 December 2020

31 December 2020

Quick facts

Lead sponsor	Guangdong Provincial People's Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	184,855
Start date	1 June 2000
Primary completion	31 December 2020
Estimated completion	31 December 2020
Sites	1 location across China

Conditions studied

• Cardio-Renal Syndrome — all drugs for Cardio-Renal Syndrome →
• Coronary Angiography — all drugs for Coronary Angiography →
• Coronary Artery Disease — all drugs for Coronary Artery Disease →
• Kidney Diseases — all drugs for Kidney Diseases →

Sponsor

Guangdong Provincial People's Hospital

Who can join

Eligibility, any sex, with Cardio-Renal Syndrome or Coronary Angiography. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

As a multi-center, retrospective observation study in southern China, this study included the main study population of patients who underwent coronary angiography at 5 hospitals from Guangzhou, Shenzhen, Yangjiang, Maoming and Longyan from January 2000 to Decemeber 2020. The hospitalization information was collected in the form of direct derivation of the case, and cardiac and renal adverse events were collected through outpatient system. Data on all-cause death were obtained from the Guangdong Provincial Public Security and matched to the electronic Clinical Management System of the Guangdong Provincial People's Hospital records.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

1. Impact of stress hyperglycemia ratio on mortality in patients with critical acute myocardial infarction: insight from american MIMIC-IV and the chinese CIN-II study.
   Liu J, Zhou Y, Huang H, Liu R, et al · · 2023 · cited 111× · PMID 37865764 · DOI 10.1186/s12933-023-02012-1
2. Association between triglyceride glucose index and worsening heart failure in significant secondary mitral regurgitation following percutaneous coronary intervention.
   Huang H, Li Q, Liu J, Qiao L, et al · · 2022 · cited 18× · PMID 36443743 · DOI 10.1186/s12933-022-01680-9
3. Elevated urine albumin creatinine ratio increases cardiovascular mortality in coronary artery disease patients with or without type 2 diabetes mellitus: a multicenter retrospective study.
   Lin X, Song W, Zhou Y, Gao Y, et al · · 2023 · cited 16× · PMID 37563647 · DOI 10.1186/s12933-023-01907-3
4. Sex Differences in Characteristics, Treatments, and In-hospital Outcomes of Patients Undergoing Coronary Angiography or Intervention.
   Chen SQ, Liu J, Zhou Y, Huang ZD, et al · · 2022 · cited 14× · PMID 35571216 · DOI 10.3389/fcvm.2022.878566
5. Association Between Systemic Immune Inflammation Level and Poor Prognosis Across Different Glucose Metabolism Status in Coronary Artery Disease Patients.
   Xu X, Xie Y, Gu X, Zhou Y, et al · · 2023 · cited 11× · PMID 37719940 · DOI 10.2147/jir.s425189
6. Impact of Platelet-to-HDL-Cholesterol Ratio on Long-Term Mortality in Coronary Artery Disease Patients with or Without Type 2 Diabetes: Insights from a Chinese Multicenter Cohort.
   Wu W, Jia C, Xu X, He Y, et al · · 2024 · cited 10× · PMID 38737110 · DOI 10.2147/jir.s458950
7. Prognostic value of the prognostic nutritional index for patients with acute myocardial infarction undergoing percutaneous coronary intervention with variable glucose metabolism statuses: a retrospective cohort study.
   Ling X, Lin C, Liu J, He Y, et al · · 2023 · cited 8× · PMID 37875955 · DOI 10.1186/s13098-023-01160-4
8. Fibrinogen-to-Albumin Ratio and Long-Term Mortality in Coronary Artery Disease Patients with Different Glucose Metabolism Status.
   Xie Y, Xu X, Wang D, Zhou Y, et al · · 2023 · cited 7× · PMID 39076427 · DOI 10.31083/j.rcm2411317